Plasmid DNA (pDNA) is a critical raw material for the manufacture of cell and gene therapies. As this market continues to grow, so too does the demand for high-quality pDNA.
Barry J. Oliver
Advertisement
Barry J. Oliver, vice president, Quality, Catalent Cell, Gene & Protein Therapies.
Articles by Barry J. Oliver
Advertisement
Latest Updated Articles
Plasmid DNA—The Versatile Building BlockPublished: September 16th 2023 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
CPHI Frankfurt 2025 Highlights Global Pharma Innovation and Manufacturing Leadership
2
A-TEEM: A Novel, Powerful Tool for Evaluating and Monitoring Cell Culture Media
3
AstraZeneca Lupus Treatment Support in EU Opens Door for Self-Administration Options
4
Behind the Headlines Episode 27: Unpacking Mega Deals and R&D Directions
5
